Search

Your search keyword '"Bui HM"' showing total 5 results
Start Over Author "Bui HM" Publisher elsevier bv
5 results on '"Bui HM"'

1. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

Author

Trujillo‐Santos, Javier, primary, Farge‐Bancel, Dominique, additional, Pedrajas, José María, additional, Gómez‐Cuervo, Covadonga, additional, Ballaz, Aitor, additional, Braester, Andrei, additional, Mahé, Isabelle, additional, Villalobos, Aurora, additional, Porras, José Antonio, additional, Monreal, Manuel, additional, Adarraga, MD, additional, Aibar, J, additional, Aibar, MA, additional, Amado, C, additional, Arcelus, JI, additional, Asuero, A, additional, Barba, R, additional, Barbagelata, C, additional, Barrón, M, additional, Barrón‐Andrés, B, additional, Blanco‐Molina, A, additional, Botella, E, additional, Camon, AM, additional, Casado, I, additional, Castro, J, additional, Castro, M, additional, Chasco, L, additional, Criado, J, additional, de Ancos, C, additional, del Toro, J, additional, Demelo‐Rodríguez, P, additional, Díaz‐Brasero, AM, additional, Díaz‐Peromingo, JA, additional, Di Campli, MV, additional, Dubois‐Silva, A, additional, Escribano, JC, additional, Espósito, F, additional, Falgá, C, additional, Farfán‐Sedano, AI, additional, Fernández‐Capitán, C, additional, Fernández‐Reyes, JL, additional, Fidalgo, MA, additional, Flores, K, additional, Font, C, additional, Font, L, additional, Francisco, I, additional, Gabara, C, additional, Galeano‐Valle, F, additional, García, MA, additional, García‐Bragado, F, additional, García de Herreros, M, additional, García de la Garza, R, additional, García‐Díaz, C, additional, García‐Hernáez, R, additional, García‐Raso, A, additional, Gil‐Díaz, A, additional, Giménez‐Suau, M, additional, Grau, E, additional, Guirado, L, additional, Gutiérrez, J, additional, Hernández‐Blasco, L, additional, Hernando, E, additional, Jara‐Palomares, L, additional, Jaras, MJ, additional, Jiménez, D, additional, Jiménez, R, additional, Jiménez‐Alfaro, C, additional, Joya, MD, additional, Lainez‐Justo, S, additional, Latorre, A, additional, Lima, J, additional, Llamas, P, additional, Lobo, JL, additional, López‐Jiménez, L, additional, López‐Miguel, P, additional, López‐Núñez, JJ, additional, López‐Reyes, R, additional, López‐Sáez, JB, additional, Lorenzo, A, additional, Madridano, O, additional, Maestre, A, additional, Marchena, PJ, additional, Martín‐Martos, F, additional, Martínez‐Urbistondo, D, additional, Mella, C, additional, Mercado, MI, additional, Moisés, J, additional, Morales, MV, additional, Muñoz‐Blanco, A, additional, Muñoz‐Rivas, N, additional, Navas, MS, additional, Nieto, JA, additional, Nofuentes‐Pérez, E, additional, Núñez‐Fernández, MJ, additional, Obispo, B, additional, Olid, M, additional, Olivares, MC, additional, Orcastegui, JL, additional, Osorio, J, additional, Otalora, S, additional, Otero, R, additional, Paredes, D, additional, Parra, P, additional, Pellejero, G, additional, Portillo, J, additional, Rivera‐Civico, F, additional, Rodríguez‐Chiaradía, DA, additional, Rodríguez‐Matute, C, additional, Rogado, J, additional, Rosa, V, additional, Ruiz‐Artacho, P, additional, Ruiz‐Giménez, N, additional, Ruiz‐Ruiz, J, additional, Ruiz‐Sada, P, additional, Salgueiro, G, additional, Sánchez‐Martínez, R, additional, Sánchez‐Muñoz‐Torrero, JF, additional, Sancho, T, additional, Soler, S, additional, Suárez‐Rodríguez, B, additional, Suriñach, JM, additional, Tirado, R, additional, Torres, MI, additional, Tolosa, C, additional, Uresandi, F, additional, Valero, B, additional, Valle, R, additional, Varona, JF, additional, Vidal, G, additional, Villares, P, additional, Zamora, C, additional, Engelen, M, additional, Vanassche, T, additional, Verhamme, P, additional, Hirmerova, J, additional, Malý, R, additional, Ait Abdallah, N, additional, Bertoletti, L, additional, Bura‐Riviere, A, additional, Catella, J, additional, Couturaud, F, additional, Crichi, B, additional, Debourdeau, P, additional, Espitia, O, additional, Falvo, N, additional, Helfer, H, additional, Lacut, K, additional, Le Mao, R, additional, Moustafa, F, additional, Poenou, G, additional, Quere, I, additional, Schellong, S, additional, Brenner, B, additional, Tzoran, I, additional, Nikandish, R, additional, Bilora, F, additional, Brandolin, B, additional, Ciammaichella, M, additional, Di Micco, P, additional, Imbalzano, E, additional, Maida, R, additional, Pace, F, additional, Pesavento, R, additional, Prandoni, P, additional, Quintavalla, R, additional, Rocci, A, additional, Siniscalchi, C, additional, Tufano, A, additional, Visonà, A, additional, Zalunardo, B, additional, Birzulis, J, additional, Skride, A, additional, Zaicenko, A, additional, Fonseca, S, additional, Martins, F, additional, Meireles, J, additional, Bosevski, M, additional, Bounameaux, H, additional, Mazzolai, L, additional, Ochoa‐Chaar, CI, additional, Weinberg, I, additional, and Bui, HM, additional

Published
2022
Full Text
View/download PDF

2. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

Author

Blondon, Marc, primary, Jimenez, David, additional, Robert‐Ebadi, Helia, additional, Del Toro, Jorge, additional, Lopez‐Jimenez, Luciano, additional, Falga, Conxita, additional, Skride, Andris, additional, Font, Llorenç, additional, Vazquez, Fernando Javier, additional, Bounameaux, Henri, additional, Monreal, Manuel, additional, Prandoni, Paolo, additional, Brenner,, Benjamin, additional, Farge‐Bancel, Dominique, additional, Barba, Raquel, additional, Di Micco, Pierpaolo, additional, Bertoletti, Laurent, additional, Schellong, Sebastian, additional, Tzoran, Inna, additional, Reis, Abilio, additional, Bosevski, Marijan, additional, Malý, Radovan, additional, Verhamme, Peter, additional, Caprini, Joseph A, additional, My Bui, Hanh, additional, Adarraga, MD, additional, Agud, M, additional, Aibar, J, additional, Aibar, MA, additional, Alfonso, J, additional, Amado, C, additional, Arcelus, JI, additional, Baeza, C, additional, Ballaz, A, additional, Barba, R, additional, Barbagelata, C, additional, Barrón, M, additional, Barrón‐Andrés, B, additional, Blanco‐Molina, A, additional, Botella, E, additional, Camon, AM, additional, Castro, J, additional, Caudevilla, MA, additional, Cerdà, P, additional, Chasco, L, additional, Criado, J, additional, de Ancos, C, additional, de Miguel, J, additional, Demelo‐Rodríguez, P, additional, Díaz‐Peromingo, JA, additional, Díez‐Sierra, J, additional, Díaz‐Simón, R, additional, Domínguez, IM, additional, Encabo, M, additional, Escribano, JC, additional, Falgá, C, additional, Farfán, AI, additional, Fernández‐Capitán, C, additional, Fernández‐Reyes, JL, additional, Fidalgo, MA, additional, Flores, K, additional, Font, C, additional, Francisco, I, additional, Gabara, C, additional, Galeano‐Valle, F, additional, García, MA, additional, García‐Bragado, F, additional, García‐Mullor, MM, additional, Gavín‐Blanco, O, additional, Gavín‐Sebastián, O, additional, Gil‐Díaz, A, additional, Gómez‐Cuervo, C, additional, González‐Martínez, J, additional, Grau, E, additional, Guirado, L, additional, Gutiérrez, J, additional, Hernández‐Blasco, L, additional, Jara‐Palomares, L, additional, Jaras, MJ, additional, Jiménez, D, additional, Joya, MD, additional, Jou, I, additional, Lacruz, B, additional, Lecumberri, R, additional, Lima, J, additional, Lobo, JL, additional, López‐Brull, H, additional, López‐Jiménez, L, additional, López‐Miguel, P, additional, López‐Núñez, JJ, additional, López‐Reyes, R, additional, López‐Sáez, JB, additional, Lorente, MA, additional, Lorenzo, A, additional, Loring, M, additional, Madridano, O, additional, Maestre, A, additional, Marchena, PJ, additional, Martín del Pozo, M, additional, Martín‐Martos, F, additional, Martínez‐Baquerizo, C, additional, Mella, C, additional, Mellado, M, additional, Mercado, MI, additional, Moisés, J, additional, Morales, MV, additional, Muñoz‐Blanco, A, additional, Muñoz‐Guglielmetti, D, additional, Muñoz‐Rivas, N, additional, Nart, E, additional, Nieto, JA, additional, Núñez, MJ, additional, Olivares, MC, additional, Ortega‐Michel, C, additional, Ortega‐Recio, MD, additional, Osorio, J, additional, Otalora, S, additional, Otero, R, additional, Parra, P, additional, Parra, V, additional, Pedrajas, JM, additional, Pellejero, G, additional, Pérez‐Jacoiste, A, additional, Peris, ML, additional, Pesántez, D, additional, Porras, JA, additional, Portillo, J, additional, Reig, L, additional, Riera‐Mestre, A, additional, Rivas, A, additional, Rodríguez‐Cobo, A, additional, Rodríguez‐Matute, C, additional, Rogado, J, additional, Rosa, V, additional, Rubio, CM, additional, Ruiz‐Artacho, P, additional, Ruiz‐Giménez, N, additional, Ruiz‐Ruiz, J, additional, Ruiz‐Sada, P, additional, Sahuquillo, JC, additional, Salgueiro, G, additional, Sampériz, A, additional, Sánchez‐Muñoz‐Torrero, JF, additional, Sancho, T, additional, Sigüenza, P, additional, Sirisi, M, additional, Soler, S, additional, Suárez, S, additional, Suriñach, JM, additional, Tiberio, G, additional, Torres, MI, additional, Tolosa, C, additional, Trujillo‐Santos, J, additional, Uresandi, F, additional, Usandizaga, E, additional, Valle, R, additional, Vela, JR, additional, Vidal, G, additional, Vilar, C, additional, Villares, P, additional, Zamora, C, additional, Gutiérrez, P, additional, Vázquez, FJ, additional, Vanassche, T, additional, Vandenbriele, C, additional, Verhamme, P, additional, Hirmerova, J, additional, Malý, R, additional, Salgado, E, additional, Benzidia, I, additional, Bertoletti, L, additional, Bura‐Riviere, A, additional, Crichi, B, additional, Debourdeau, P, additional, Espitia, O, additional, Farge‐Bancel, D, additional, Helfer, H, additional, Mahé, I, additional, Moustafa, F, additional, Poenou, G, additional, Schellong, S, additional, Braester, A, additional, Brenner, B, additional, Tzoran, I, additional, Amitrano, M, additional, Bilora, F, additional, Bortoluzzi, C, additional, Brandolin, B, additional, Ciammaichella, M, additional, Colaizzo, D, additional, Dentali, F, additional, Di Micco, P, additional, Giammarino, E, additional, Grandone, E, additional, Mangiacapra, S, additional, Mastroiacovo, D, additional, Maida, R, additional, Mumoli, N, additional, Pace, F, additional, Pesavento, R, additional, Pomero, F, additional, Prandoni, P, additional, Quintavalla, R, additional, Rocci, A, additional, Siniscalchi, C, additional, Tufano, A, additional, Visonà, A, additional, Vo Hong, N, additional, Zalunardo, B, additional, Kalejs, RV, additional, Maķe, K, additional, Ferreira, M, additional, Fonseca, S, additional, Martins, F, additional, Meireles, J, additional, Bosevski, M, additional, Zdraveska, M, additional, Mazzolai, L, additional, Caprini, JA, additional, Tafur, AJ, additional, Weinberg, I, additional, Wilkins, H, additional, and Bui, HM, additional

Published
2021
Full Text
View/download PDF

3. Venous thromboembolism in young adults: Findings from the RIETE registry

Author

Lacruz, B, Tiberio, G, Latorre, A, Villalba, JC, Bikdeli, B, Hirmerova, J, Lorenzo, A, Mellado, M, Canas, I, Monreal, M, Adarraga, MD, Agud, M, Agudo, P, Aibar, MA, Aibar, J, Amado, C, Arcelus, JI, Ballaz, A, Barba, R, Barron, M, Barron-Andres, B, Bascunana, J, Bolado, C, Blanco-Molina, A, Camon, AM, Carrasco, C, Castro, J, de Ancos, C, del Toro, J, Demelo, P, Diaz-Simon, R, Diaz-Peromingo, JA, Encabo, M, Falga, C, Farfan, AI, Fernandez-Capitan, C, Fernandez-Criado, MC, Fernandez-Ovalle, H, Fidalgo, MA, Font, C, Font, L, Furest, I, Garcia, MA, Garcia-Bragado, F, Garcia-Morillo, M, Garcia-Raso, A, Gavin, O, Gaya-Manso, I, Gayol, MC, Gil-Diaz, A, Gomez, V, Gomez-Cuervo, C, Gonzalez-Martinez, J, Grau, E, Gutierrez, J, Hernandez-Blasco, LM, Iglesias, M, Jara-Palomares, L, Jaras, MJ, Jimenez, D, Jou, I, Joya, MD, Lalueza, A, Lima, J, Llamas, P, Lobo, JL, Lopez-Jimenez, L, Lopez-Miguel, P, Lopez-Nunez, JJ, Lopez-Reyes, R, Lopez-Saez, JB, Lorente, MA, Loring, M, Madridano, O, Maestre, A, Marchena, PJ, Martin, M, Martin-Fortea, MP, Martin-Guerra, JM, Martinez-Gonzalez, L, Melia, C, Montesa, C, Morales, MV, Nieto, MA, Nieto, JA, Nunez, MJ, Olivares, MC, Otalora, S, Otero, R, Ovejero, A, Pedrajas, JM, Pellejero, G, Perez-Ductor, C, Perez-Pinar, M, Perez-Rus, G, Penis, ML, Porras, JA, Redrado, J, Rivas, A, Rodriguez-Galan, I, Rodriguez-Hernandez, A, Rubio, CM, Ruiz-Artacho, P, Ruiz-Ruiz, J, Ruiz-Sada, P, Sahuquillo, JC, Sala-Sainz, MC, Salazar, V, Salgueiro, G, Samperiz, A, Sanchez-Camara, S, Sanchez-Munoz-Torrero, JF, Sancho, T, Soler, S, Surinach, JM, Tolosa, C, Torres, MI, Trujillo-Santos, J, Uresandi, F, Valle, R, Vidal, G, Villares, P, Gutierrez, P, Vazquez, FJ, Vilaseca, A, Vanassche, T, Vandenbriele, C, Verhamme, P, Yoo, HHB, Maly, R, Salgado, E, Benzidia, I, Bertoletti, L, Bura-Riviere, A, Debourdeau, P, Farge-Bancel, D, Hij, A, Mahe, I, Merah, A, Moustafa, F, Schellong, S, Braester, A, Brenner, B, Ellis, M, Tzoran, I, Sharif-Kashani, B, Barillari, G, Bilora, F, Bortoluzzi, C, Brandolin, B, Ciammaichella, M, Dentali, F, Di Micco, P, Grandone, E, Maida, R, Mastroiacovo, D, Pace, F, Parisi, R, Pesavento, R, Prandoni, P, Quintavalla, R, Rocci, A, Siniscalchi, C, Sotgiu, P, Tufano, A, Visona, A, Hong, NV, Gibietis, V, Kigitovica, D, Skride, A, Bosevski, M, Bounameaux, H, Mazzolai, L, Caprini, J, Bui, HM, and Pham, KQ

Subjects
Young, Anticoagulants, Outcomes, Venous thromboembolism
Abstract

Background: Little is known on the clinical characteristics, risk factors and outcomes during anticoagulation in young patients with acute venous thromboembolism (VTE). Methods: We used data from the RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry to assess the clinical characteristics, risk factors and outcomes during anticoagulation in VTE patients aged 10-24 years. Data were separately analyzed according to initial presentation and gender. Results: Of 76,719 patients with VTE, 1571 (2.0%) were aged 10-24 years. Of these, 989 (63%) were women and 669 (43%) presented with pulmonary embolism (PE). Most women were using estrogens (680, 69%) or were pregnant (101, 10%), while 59% of men had unprovoked VTE. Women were more likely to present with PE (48% vs. 34%). The majority (87%) of PE patients had Sat O-2 levels >= 90% at baseline. The vast majority (97%) of PE patients were at low risk according to the PESI score, many (90%) at very low risk. During the course of anticoagulation (median, 192 days), 40 patients had VTE recurrences, 17 had major bleeding and 10 died (3 died of PE). Women had as many VTE recurrences as major bleeds (15 vs. 14 events), while men had many more VTE recurrences than major bleeding (25 vs. 3 events). Conclusions: VTE is associated with low risk of short-term mortality in young adults. Noticeable gender differences exist in the risk factor profile and the risk of VTE recurrences and major bleeding in the course of anticoagulation.

Published
2019

4. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

Author

Siniscalchi, C, Quintavalla, R, Rocci, A, Riera-Mestre, A, Trujillo-Santos, J, Surinach, JM, Jara-Palomares, L, Bikdeli, B, Moustafa, F, Monreal, M, Adarraga, MD, Agud, M, Aibar, MA, Alfonso, J, Amado, C, Arcelus, JI, Ballaz, A, Barba, R, Barbagelata, C, Barron, M, Barron-Andres, B, Blanco-Molina, A, Camon, AM, Canas, I, Carrasco, C, Castro, J, Chasco, L, Cerda, P, Demelo, P, Diaz-Peromingo, JA, Elias-Hernandez, T, Encabo, M, Escribano, JC, Falga, C, Farfan, AI, Fernandez-Capitan, C, Fernandez-Criado, MC, Fidalgo, MA, Font, C, Font, L, Furest, I, Galian, JD, Garcia, MA, Garcia-Bragado, F, Garcia-Raso, A, Gavin, O, Gayol, MC, Gil-Diaz, A, Gomez, V, Gomez-Cuervo, C, Gonzalez-Martinez, J, Grau, E, Gutierrez, J, Hernandez-Blasco, LM, Iglesias, M, Jaras, MJ, Jimenez, D, Jimenez, R, Joya, MD, Jou, I, Lalueza, A, Lecumberri, R, Lima, J, Llamas, P, Lobo, JL, Lopez-Jimenez, L, Lopez-Miguel, P, Lopez-Nunez, JJ, Lopez-Reyes, R, Lopez-Saez, JB, Lorente, MA, Lorenzo, A, Loring, M, Lumbierres, M, Madridano, O, Maestre, A, Marchena, PJ, del Pozo, MM, Martin-Fortea, P, Martin-Martos, F, Martinez-Garcia, MA, Martinez-Gonzalez, L, Mella, C, Mellado, M, Montesa, C, Morales, MV, Nieto, JA, Nunez, MJ, Olivares, MC, Olivera, PE, Ortega-Michel, C, Otalora, S, Otero, R, Panadero-Macia, M, Pedrajas, JM, Pellejero, G, Perez-Ductor, C, Perez-Jacoiste, A, Perez-Rus, G, Penis, ML, Pesantez, D, Porras, JA, Rivas, A, Rodriguez-Cobo, A, Rodriguez-Hernandez, A, Rubio, CM, Ruiz-Artacho, P, Ruiz-Ruiz, J, Ruiz-Sada, P, Sahuquillo, JC, Sala-Sainz, MC, Salazar, V, Salgueiro, G, Samperiz, A, Sanchez-Munoz-Torrero, JF, Sancho, T, Soler, S, Suarez, S, Tolosa, C, Torres, MI, Uresandi, F, Valle, R, Vela, JR, Vidal, G, Villares, P, de Ancos, C, del Toro, J, Gutierrez, P, Vazquez, FJ, Vilaseca, A, Vanassche, T, Vandenbriele, C, Verhamme, P, Yoo, HHB, Hirmerova, J, Maly, R, Salgado, E, Benzidia, I, Bertoletti, L, Bura-Riviere, A, Debourdeau, P, Farge-Bancel, D, Helfer, H, Hij, A, Mahe, I, Schellong, S, Braester, A, Brenner, B, Tzoran, I, Sharif-Kashani, B, Barillari, G, Bilora, F, Bortoluzzi, C, Brandolin, B, Ciammaichella, M, Dentali, F, Di Micco, P, Imbalzano, E, Landolfi, R, Maida, R, Mastroiacovo, D, Pace, F, Pesavento, R, Pomero, F, Prandoni, P, Tufano, A, Ventresca, A, Visona, A, Hong, NV, Zalunardo, B, Gibietis, V, Kigitovica, D, Skride, A, Bosevski, M, Bounameaux, H, Mazzolai, L, Caprini, J, and Bui, HM

Subjects
Venous thomboembolism, Fatal bleeding, Statins, Death all-causes, Fatal pulmonary embolism
Abstract

Background: The clinical outcomes during the course of anticoagulation in patients with venous thromboem-bolism (VTE) using statins remain controversial. Methods: We used the RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry to compare the risk for VTE recurrences, major bleeding or death during anticoagulation, according to the use of statins at baseline. We used propensity score-matching (PSM) to adjust for confounding variables. Results: From February 2009 to January 2018, 32,062 VTE patients were included. Of these, 7,085 (22%) were using statins. Statin users were 10 years older (73 +/- 11 vs. 63 +/- 19 years, respectively) and more likely to have comorbidities or to be using antiplatelets or corticosteroids at baseline than non-users. During the course of anticoagulation (median, 177 days), 694 patients developed VTE recurrences, 848 bled and 3,169 died (fatal pulmonary embolism 176, fatal bleeding 121). Statin users had a similar rate of VTE recurrences (hazard ratio [HR]: 0.98; 95%CI: 0.82-1.17), a higher rate of major bleeding (HR: 1.29; 95%CI: 1.11-1.50) and a similar mortality rate (HR: 1.01; 95%CI: 0.93-1.10) than non-users. On PSM analysis, statin users had a significantly lower risk for death (HR: 0.62; 95%CI: 0.48-0.79) and a similar risk for VTE recurrences (HR: 0.98; 95%CI: 0.61-1.57) or major bleeding (HR: 0.85; 95%CI: 0.59-1.21) than non-users. Conclusions: During anticoagulation for VTE, patients using statins at baseline had a lower risk to die than nonusers.

Published
2019

5. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry

Author

de Miguel-Diez, J, Lopez-de-Andres, A, Jimenez-Trujillo, I, Hernandez-Barrera, V, Jimenez-Garcia, R, Lorenzo, A, Pedrajas, JM, Visona, A, Lopez-Miguel, P, Monreal, M, Adarraga, MD, Aibar, MA, Aibar, J, Alfonso, M, Amado, C, Aranda, C, Arcelus, JI, Ballaz, A, Barba, R, Barron, M, Barron-Andres, B, Bascunana, J, Blanco-Molina, A, Camon, AM, Carrasco, C, Cruz, AJ, del Toro, J, Diaz-Pedroche, MC, Diaz-Peromingo, JA, Falga, C, Fernandez-Capitan, C, Fidalgo, MA, Font, C, Font, L, Furest, I, Garcia, MA, Garcia-Bragado, F, Garcia-Morillo, M, Garcia-Ortega, A, Gavin, O, Gomez, V, Gonzalez-Martinez, J, Grau, E, Guijarro, R, Guirado, L, Gutierrez, J, Hernandez-Blasco, L, Isern, V, Jara-Palomares, L, Jaras, MJ, Jimenez, D, Jimenez, J, Jou, I, Joya, MD, Lalueza, A, Lima, J, Lobo, JL, Lopez-Jimenez, L, Lopez-Reyes, R, Lopez-Saez, JB, Lorente, MA, Loring, M, Lumbierres, M, Madridano, O, Marchena, PJ, Martin-Martos, Morales, MV, Nieto, JA, Nunez, A, Nunez, MJ, Olivares, MC, Otalora, S, Otero, R, Pellejero, G, Perez-Ductor, C, Perez-Jacoiste, A, Penis, ML, Pesce, ML, Porras, JA, Riesco, D, Rivas, A, Rodriguez-Davila, MA, Rosa, V, Rubio, CM, Ruiz-Artacho, P, Sahuquillo, JC, Sala-Sainz, MC, Samperiz, A, Sanchez-Munoz-Torrero, JF, Sancho, T, Soler, S, Soto, MJ, Surinach, JM, Tolosa, C, Torrents, A, Torres, MI, Trujillo-Santos, J, Uresandi, F, Usandizaga, E, Valle, R, Vela, J, Vidal, G, Villalobos, A, Gutierrez, P, Vazquez, FJ, Vilaseca, A, Vanasschc, T, Vandenbriele, C, Verhamme, P, Hirmerova, J, Maly, R, Salgado, E, Benzidia, I, Bertoletti, L, Bura-Riviere, A, Farge-Bancel, D, Hij, A, Merah, A, Mahe, I, Moustafa, F, Braester, A, Brenner, B, Ellis, M, Tzoran, I, Bilora, F, Bortoluzzi, C, Brandolin, B, Bucherini, E, Cattabiani, C, Ciammaichella, M, Dentali, F, Di Micco, P, Giorgi-Pierfranceschi, M, Grandone, E, Imbalzano, E, Maida, R, Mastroiacovo, D, Ngoc, V, Pace, F, Parisi, R, Pesavento, R, Prandoni, P, Quintavalla, R, Rocci, A, Siniscalchi, C, Sotgiu, P, Tiraferri, E, Tufano, A, Zalunardo, B, Kalejs, R, Skride, A, Vitola, B, Bosevski, M, Zdraveska, M, Ii, B, Fresa, M, Mazzolai, L, Caprini, J, and Bui, HM

Subjects
Cardiovascular events, Type 2 diabetes mellitus, Pulmonary embolism, Comorbidity, Mortality
Abstract

Background: Among patients presenting with pulmonary embolism (PE), those with diabetes are at increased risk to die than those without diabetes. The reasons have not been identified. We used the RIETE (Registro Informatizado Enfermedad Trombo Embolica) database to compare the mortality rate and the causes of death during anticoagulation in patients with PE according to the presence or absence of diabetes. Methods: A matched retrospective cohort study from consecutively enrolled patients in RIETE, from 179 hospitals in 24 countries. For each patient with diabetes we selected two patients with no diabetes matched by age, sex and year of diagnosis of the PE. Results: As of September 2017, there were 2010 PE patients with diabetes and two age-and-gender matched controls. Mean age was 74 +/- 11 years, 46% were men. Patients with diabetes were more likely to have comorbidities, to be using antiplatelets and to have more severe PE. During anticoagulation (median, 219 days), patients with diabetes had a higher mortality (hazard ratio [HR]: 1.45; 95% confidence intervals [CI]: 1.25-1.67) and a higher rate of arterial ischemic events (HR: 2.89; 95%CI: 1.71-4.94) than those without diabetes. On multivariable analysis, diabetes was not associated with an increased risk for death (HR: 1.26; 95%CI: 0.97-1.63). We also failed to find differences according to the use of antiplatelet drugs concomitantly. Conclusions: In our cohort of patients with PE, diabetes was not an independent predictor for death. The influence of arterial events or antiplatelet drugs (if any) was low.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results